Skip Navigation


eCAM Advance Access originally published online on January 28, 2005
eCAM 2005 2(1):25-28; doi:10.1093/ecam/neh057
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
2/1/25    most recent
neh057v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bonnemain, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonnemain, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author (2005). Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions{at}oupjournals.org

Review

Helix and Drugs: Snails for Western Health Care From Antiquity to the Present

Bruno Bonnemain

58 rue du Maréchal Joffre, 77270, Villeparisis, France

The land helix, or snail, has been used in medicine since antiquity and prepared according to several formulations. This historical report traces the understanding of their properties from the time of Hippocrates, who proposed the use of snail mucus against protoccle and Pliny who thought that the snail increased the speed of delivery and was "a sovereign remedy to treat pain related to burns, abscesses and other wounds", Galien recommended snails against hydrops foetails. In the 18th century, various snail "preparations" were also recommended for external use with dermatological disorders and internally for symptoms associated with tuberculosis and nephritis. Surprisingly, the 19th century saw a renewed interest in the pharmaceutical and medical use of snails with numerous indications for snail preparations. This interest in snails did not stop at the end of the 19th century. The 1945 edition of Dorvault devotes an entire paragraph to snails, indicating that the therapeutic usage of snails was still alive at that time. Recently the FDA has also shown an interest in snails. Ziconotide (SNXIII), a synthetic peptide coming from snail venom, has been under FDA review since 1999. Pre-clinical and clinical studies of this new drug are promising.

Keywords: Snail – helix – medical history

For reprints and all correspondence: Bruno Bonnemain, 58 rue du Maréchal Joffre, 77270, Villeparisis, France. E-mail: bruno.bonnemain{at}wanadoo.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
B. Graz
Prognostic Ability of Practitioners of Traditional Arabic Medicine: Comparison with Western Methods Through a Relative Patient Progress Scale
Evid. Based Complement. Altern. Med., March 13, 2008; (2008) nen022v1.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
E. L. Cooper
The Amazing Science Behind Nature's 'Miracle From The Sea'
Evid. Based Complement. Altern. Med., December 1, 2005; 2(4): 569 - 570.
[Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
E. L. Cooper
eCAM benefits from diversity that derives from CAM
Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 263 - 265.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.